Cargando…

P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY

Detalles Bibliográficos
Autores principales: Qiu, Ying, Chen, Jiafan, Sajeev, Gautam, Wang, Yao, Ye, Dongni, Ye, Mingchen, Chen, Jingyi, Quintana, Allison, Byrne, Clare, Huggar, David, Heydendael, Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429164/
http://dx.doi.org/10.1097/01.HS9.0000969252.00953.ba
_version_ 1785090642347556864
author Qiu, Ying
Chen, Jiafan
Sajeev, Gautam
Wang, Yao
Ye, Dongni
Ye, Mingchen
Chen, Jingyi
Quintana, Allison
Byrne, Clare
Huggar, David
Heydendael, Willem
author_facet Qiu, Ying
Chen, Jiafan
Sajeev, Gautam
Wang, Yao
Ye, Dongni
Ye, Mingchen
Chen, Jingyi
Quintana, Allison
Byrne, Clare
Huggar, David
Heydendael, Willem
author_sort Qiu, Ying
collection PubMed
description
format Online
Article
Text
id pubmed-10429164
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291642023-08-17 P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY Qiu, Ying Chen, Jiafan Sajeev, Gautam Wang, Yao Ye, Dongni Ye, Mingchen Chen, Jingyi Quintana, Allison Byrne, Clare Huggar, David Heydendael, Willem Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429164/ http://dx.doi.org/10.1097/01.HS9.0000969252.00953.ba Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Qiu, Ying
Chen, Jiafan
Sajeev, Gautam
Wang, Yao
Ye, Dongni
Ye, Mingchen
Chen, Jingyi
Quintana, Allison
Byrne, Clare
Huggar, David
Heydendael, Willem
P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title_full P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title_fullStr P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title_full_unstemmed P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title_short P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
title_sort p587: real-world characteristics and use of antiemetic therapies among patients with acute myeloid leukemia treated with oral azacitidine maintenance therapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429164/
http://dx.doi.org/10.1097/01.HS9.0000969252.00953.ba
work_keys_str_mv AT qiuying p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT chenjiafan p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT sajeevgautam p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT wangyao p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT yedongni p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT yemingchen p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT chenjingyi p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT quintanaallison p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT byrneclare p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT huggardavid p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy
AT heydendaelwillem p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy